Policy Notices

• AHRQ Policy on the Inclusion of Priority Populations in Research
  (NOT-HS-21-015)
  Agency for Healthcare Research and Quality
  

• Announcing New Inbox for Inquiries Related to Changes to Biographical Sketch and Other Support Format Page
  (NOT-OD-21-122)
  National Institutes of Health
  

General Notices

• Notice of Information: Availability of DNA and RNA Samples from the NIAAA-Sponsored Clinical Trial of Gabapentin Enacarbil Extend-Release
  (NOT-AA-21-032)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Information: NIDA Extensions for NRSA Fellowships and Career Development Award Recipients Whose Career Trajectories Have Been Significantly Affected by COVID-19
  (NOT-DA-21-046)
  National Institute on Drug Abuse
  

• Notice of Pre-Application Information Webinar for PAR-21-183, "Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)"
  (NOT-DA-21-052)
  National Institute on Drug Abuse
  

• NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic
  (NOT-DK-21-019)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of a Pre-Application Technical Assistance Webinar for NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
  (NOT-NS-21-067)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice to Extend the Response Date for NOT-OD-21-108 "Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program"
  (NOT-OD-21-129)
  National Institutes of Health
  

• Request for Information (RFI): Inviting Comments and Suggestions on the Impact of Radiation Exposure from a Radiological or Nuclear Incident on the Microbiome and the Development of Targeted Therapeutics
  (NOT-AI-21-055)
  National Institute of Allergy and Infectious Diseases
  

• Request for Information (RFI): Inviting Comments on Developing Evidence-Based Music Therapies for Brain Disorders of Aging
  (NOT-AT-21-011)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  

• Request for Information (RFI): Access and use of data from the Adolescent Brain Cognitive Development (ABCD) Study
  (NOT-DA-21-055)
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Request for Information: Input to the National Eye Institute Strategic Plan Draft Document
  (NOT-EY-21-010)
  National Eye Institute
  

Notice of Changes to Funding Opportunities

• Notice of Change to Award Information in PAR-21-082, "NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
  (NOT-AI-21-053)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Change of Second Available Due Date for NOT-HD-20-008, Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies
  (NOT-HD-21-034)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Participation of NIMH in PAR-20-125, "Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)"
  (NOT-MH-21-300)
  National Institute of Mental Health
  

• Notice of Early Termination of RFA-NS-21-016, HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
  (NOT-NS-21-061)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  

• Notice to Extend the Expiration Date for PA-18-590 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
  (NOT-OD-21-121)
  National Institutes of Health
  

• Correction to the Budget Section of PAR-21-225"Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)"
  (NOT-OD-21-123)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Correction to the Budget Section of "PAR-21-226 Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)"
  (NOT-OD-21-124)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Correction to the Eligibility Section of PAR-21-238 "Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award
  (NOT-OD-21-126)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Notice of Participation of the Office of Research on Women's Health (ORWH) in PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)"
  (NOT-OD-21-132)
  Office of Research on Women's Health
  

• Notice of Participation of the Office of Research on Women's Health (ORWH) in PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
  (NOT-OD-21-133)
  Office of Research on Women's Health
  

• Notice of Addition of Information for RFA-RM-21-021 - Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
  (NOT-RM-21-027)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Addition of Information for RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
  (NOT-RM-21-028)
  Office of Strategic Coordination (Common Fund)
  

Notices of Special Interest

• Notice of Special Interest: Advanced Computational Approaches to Elucidate Disease Pathology and Identify Novel Therapeutics for Addiction
  (NOT-DA-21-004)
  National Institute on Drug Abuse
  

• Notice of Special Interest: Administrative Supplements to Support Research on Health Equity in NIDA-funded Grant Awards
  (NOT-DA-21-044)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Administrative Supplements to support engagement of functionally diverse teams to advance ongoing NIDA-funded research
  (NOT-DA-21-045)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI) to Encourage Administrative Supplement Applications to Investigate COVID-19 Vaccination and Menstruation (Admin Supp Clinical Trial Optional)
  (NOT-HD-21-035)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Re-issue of Availability of Administrative Supplements for Submission of Tissue Chip Data to the Microphysiology Systems Database (MPS-Db)
  (NOT-TR-21-028)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  (PAR-21-154)
  National Institute on Drug Abuse
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
  (PAR-21-155)
  National Institute of General Medical Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
  (PAR-21-237)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
  (RFA-DK-21-012)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 9, 2022 and October 7, 2022
  
  

• NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  (RFA-RM-21-016)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): August 20, 2021
  
  

• Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)
  (RFA-TW-21-004)
  John E. Fogarty International Center
  National Cancer Institute
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): August 20, 2021